Drug Shortage Report for AURO-TADALAFIL
Report ID | 199891 |
Drug Identification Number | 02435934 |
Brand name | AURO-TADALAFIL |
Common or Proper name | TADALAFIL |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | TADALAFIL |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 2 X 2 Blst |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-07-24 |
Estimated end date | 2023-08-06 |
Actual end date | 2023-08-03 |
Shortage status | Resolved |
Updated date | 2023-08-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-08-08 | French | Compare |
v6 | 2023-08-08 | English | Compare |
v5 | 2023-08-02 | French | Compare |
v4 | 2023-08-02 | English | Compare |
v3 | 2023-07-25 | English | Compare |
v2 | 2023-07-24 | French | Compare |
v1 | 2023-07-24 | English | Compare |
Showing 1 to 7 of 7